Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tyrphostin A1

An inactive agent that is used as a negative control for the inhibition of epidermal growth factor receptor tyrosine kinase activity. (NCI)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Activation of antigen presenting cells through the interaction of CD40 with its ligand is a critical co-stimulatory signal for IL… Expand
Highly Cited
1999
Highly Cited
1999
IL-12 is a macrophage-derived cytokine that induces proliferation, cytokine production, and cytotoxic activity of T and NK cells… Expand
Highly Cited
1999
Highly Cited
1999
Angiotensin II is an established regulator of vascular tone and smooth muscle cell (SMC) growth. However, there are little data… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
1998
Highly Cited
1998
1 The role of protein tyrosine phosphorylation and of G proteins in the activation of a swelling‐activated Cl− current (ICl,swell… Expand
Highly Cited
1998
Highly Cited
1998
Astrocytes swell during neuronal activity as they accumulate K+ to buffer the increase in external K+ released from neurons. This… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1997
1997
1 We have studied the effect of endothelin‐1 stimulation on protein tyrosine phosphorylation levels in intact small mesenteric… Expand
Highly Cited
1997
Highly Cited
1997
1 Here we compared the effects of various inhibitors of the activity of protein tyrosine kinase on (i) the expression of the… Expand
Highly Cited
1996
Highly Cited
1996
We compared the effects of the tyrosine kinase inhibitor genistein, a naturally occurring isoflavone, to those of tyrphostin A25… Expand
Highly Cited
1995
Highly Cited
1995
The generation of oxygen-derived free radicals has been implicated in the disordered vascular regulation of inflammation and… Expand
Highly Cited
1995
Highly Cited
1995
Activation of human platelets by the peptide YFLLRNP has been shown to induce shape change but not secretion, Ca mobilization, or… Expand